A Study for the Neoadjuvant Treatment of Breast Cancer

75 mg/m2, d1, q3w,6 cycles

AUC 6, d1, q3w ,6 cycles

starting dose 8 mg/kg, maintenance dose 6 mg/kg, d1, q3w ,6 cycles

starting dose of 840 mg, maintenance dose of 420 mg, d1, q3w,6 cycles

220 mg/m2, d1, q3w,6 cycles

90 mg/m2,d1, q3w × 4 cycles,followed by docetaxel

600 mg/m2, d1, q3w ,4 cycles,followed by docetaxel

100 mg/m2, d1, q3w × 4 cycles

90 mg/m2,d1, q2w × 4 cycles,followed by nab-paclitaxel

600 mg/m2, d1, q2w × 4 cycles followed by nab-paclitaxel

125 mg/m2, d1,8,15, q3w× 4 cycles